Five GLP-1RAs are available in Australia (dulaglutide, exenatide BD, exenatide QW, liraglutide, and lixisenatide), one is undergoing regulatory approval (semaglutide), and three are currently available under the governments reimbursement scheme (dulaglutide, exenatide BD, and exenatide QW)
Wegovy and Rybelsus, both of which have semaglutide as their active ingredient, have also impacted patient vision
Always consult a licensed healthcare provider with any medical questions or concerns
If you are tolerating once-weekly dosing well If your current schedule works, do not fix what is not broken
Wolf HP
Rapid loss of lean body mass, especially muscle mass, can harm your overall health by impairing muscle strength and function, slowing metabolic rate, and increasing injury risk